Genmab says Q2 2026 DARZALEX net sales total USD 4.21 billion

PUBT · 1d ago
Genmab says Q2 2026 DARZALEX net sales total USD 4.21 billion
  • Genmab reported Q2 2026 worldwide net trade sales of DARZALEX at USD 4.21 billion, as reported by Johnson & Johnson.
  • U.S. net trade sales reached USD 2.44 billion; rest-of-world sales totaled USD 1.77 billion.
  • No percentage changes were disclosed in the update.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genmab A/S published the original content used to generate this news brief on July 15, 2026, and is solely responsible for the information contained therein.